PDL BioPharma News

TLSA: 1H:21 Financial Update

Benzinga Real-time NewsOct 7, 2021 22:10

Tianyan Pharmaceutical Announces Financial Results and Company Progress for the First Half of 2021

- Three clinical collaborations were reached with Mercadon to advance the global joint trial of three clinical antitumor candidates and pavolizumab -- ADG106 monopharmaceutical clinical trials showed efficacy and safety; focused on promoting indications with high biomarker expression and combined treatment targeting PD-1 resistant patients- - Ongoing phase I trials showed a novel anti-CTLA-4 novel epitopic antibody (NeoBodyTM) ADG116 with highly differentiated clinical product characterization -- First safe antibody project ADG126 I Phase clinical dosage climbed smoothly

美通社Aug 26, 2021 19:45

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga Real-time NewsDec 31, 2020 07:17

PDL BioPharma shares are trading higher after Silver Point Capital disclosed the purchase of 1.565 million shares.

BenzingaDec 24, 2020 19:52

PDL Biopharma 10%+ Owner Edward Mule Reported Purchase of 1,565,000 Shares @ Avg Price of $2.60/Share in Form 4 Filing on Wednesday

Benzinga Real-time NewsDec 24, 2020 18:55

PDL Biopharma 10%+ Owner Edward Mule Reported Purchase of 2,090,000 Shares @ Avg Price of $2.57/Share in Form 4 Filing on Tuesday

Benzinga Real-time NewsDec 16, 2020 18:57

Is PDLI A Good Stock To Buy Now?

Insider MonkeyDec 16, 2020 13:30

BRIEF-PDL BioPharma Enters into $51.4 Mln Capital Provision Agreement with Epps Investments LLC

路透社Dec 14, 2020 22:06

PDL BioPharma Enters $51.4M Capital Provision Agreement With Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement With Wellstat

Benzinga Real-time NewsDec 14, 2020 21:36

BRIEF-Pdl Announces Timeline For Voluntarily Delisting From Nasdaq

ReutersDec 9, 2020 05:57

PDL Announces That It Volybtarily Be Delisting From The Nasdaq On Or About December 28, 2020

Benzinga Real-time NewsDec 9, 2020 05:08

12 Healthcare Stocks Moving In Wednesday's After-Market Session

Benzinga Real-time NewsNov 12, 2020 06:38

Recap: PDL BioPharma Q3 Earnings

Benzinga Real-time NewsNov 12, 2020 06:34

PDL BioPharma shares are trading higher despite the company reporting worse-than-expected Q3 EPS and sales results.

BenzingaNov 12, 2020 06:30

PDL BioPharma Plans To File A Certificate Of Dissolution With The State Of Delaware On January 4, 2021; Stock Is Expected To Be Delisted From Nasdaq After December 31, 2020

Benzinga Real-time NewsNov 12, 2020 06:14

PDL BioPharma Q3 EPS $0.04 Misses $0.06 Estimate, Sales $4.12M Miss $5.50M Estimate

Benzinga Real-time NewsNov 12, 2020 06:07

BRIEF-Pdl Biopharma Reports 2020 Third Quarter Financial Results And Sets Date To File Certificate Of Dissolution

路透社Nov 12, 2020 05:25

PDL BioPharma 3Q EPS 4c >PDLI

Dow Jones NewswiresNov 12, 2020 05:05

PDL BioPharma to Announce Third Quarter 2020 Financial Results and Provide a Business Update on November 9, 2020

PR NewswireOct 29, 2020 20:00

Stocks That Hit 52-Week Lows On Monday

Benzinga Real-time NewsOct 19, 2020 22:17